American Psychiatric Association (1997) Practice guidelines for the treatment of patients with schizophrenia. American Journal of Psychiatry, 154, , 1–63.
Beck, N. C., Greenfield, S. R., Gotham, H., et al (1997) Risperidone in the management of violent, treatment-resistant schizophrenics hospitalized in a maximum security forensic facility. Journal of the American Academy of Psychiatry and Law, 25, 461–468.
Brecher, M. (1996) Long termsafety of risperidone (abstract P-15-1). European Neuropsychopharmacology, 6, suppl. 3, 170.
British Medical Association & Royal Pharmaceutical Society of Great Britain (2001) British National Formulary
. London & Wallingford: BMJ Books & Pharmaceutical Press.
Daniel, D. G. & Whitcomb, S. R. (1998) Treatment of the refractory schizophrenic patient. Journal of Clinical Psychiatry, 59, suppl. 1, 13–19, .
Duncan, J. C. & Rogers, R. (1998) Medication compliance in patients with chronic schizophrenia; implications for the community management of mentally disordered offenders. Journal of Forensic Psychiatry, 43, 1133–1137.
Frankenburg, F. R. (1999) Choices in antipsychotic therapy in schizophrenia. Harvard Research Review, 6, 241–249.
Lambert, T. & Singh, B. (2000) Psychotropic prescribing in community mental health clinics. International Journal of Neuropsychopharmacology, 3 (suppl.1), S123.
Norrie, P. D. & Hustig, H. H. (1998) A relevant indication for polypharmacy? The use of Zuclopenthixol with Risperidone or Olanzapine inpatients with treatment resistant schizophrenia. Poster 21st CINP, Glasgow, .
Pantelis, C. & Barnes, T. R. (1996) Drug strategies and treatment-resistant schizophrenia. Australian and New Zealand Journal of Psychiatry, 30, 20–37.
Swartz, M. S., Swanson, J.W., Hiday, V. A., et al (1998) Taking the wrong drugs: the role of substance abuse and medication noncompliance in violence among severely mentally ill individuals. Social Psychiatry and Psychiatric Epidemiology, 33, suppl.1, S75–80.
Thompson, C. (1994) The use of high dose antipsychotic medication. British Journal of Psychiatry, 164, 448–458.
Umbricht, D. & Kane, J. M. (1996) Understanding the relationship between extrapyrimidal side effects and tardive dyskinesia. In Serotonergic Mechanisms in Antipsychotic Treatment (eds. Kane, J. M., Moller, H. J. & Awouters, E.), pp. 221–251. NewYork: Marcel Dekker.
Weiden, P. J., Aquila, R., Emanuel, M., et al (1998) Long term considerations after switching antipsychotics. Journal of Clinical Psychiatry, 159, suppl. 19, 36–49.
Young, J. L., Zonana, H.V. & Shepler, L. (1986) Medication noncompliance in schizophrenia: codification and update. Bulletin of the American Academy of Psychiatry and Law, 14, 105–122.